The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Abivax SA | SPONSORED ADS | 00370M103 | 76,757,760 | 576,000 | SH | DFND | 2 | 576,000 | 0 | 0 | |
| Absci Corp | COM | 00091E109 | 28,682,515 | 2,474,764 | SH | DFND | 2 | 2,474,764 | 0 | 0 | |
| Adagene Inc | ADS | 005329107 | 11,199,997 | 2,666,666 | SH | DFND | 2 | 2,666,666 | 0 | 0 | |
| Aeva Technologies Inc | COM NEW | 00835Q202 | 4,177,582 | 145,459 | SH | DFND | 2 | 145,459 | 0 | 0 | |
| Agenus Inc | COM NEW | 00847G804 | 3,256,605 | 1,064,250 | SH | DFND | 2 | 1,064,250 | 0 | 0 | |
| Agomab Therapeutics NV | SPONSORED ADS | 00860C102 | 5,338,025 | 411,250 | SH | DFND | 2 | 411,250 | 0 | 0 | |
| Alibaba Group Holding Ltd | SPONSORED ADS | 01609W102 | 4,799,000 | 50,000 | SH | DFND | 2 | 50,000 | 0 | 0 | |
| Alphabet Inc | CAP STK CL A | 02079K305 | 32,163,300 | 90,000 | SH | DFND | 2 | 90,000 | 0 | 0 | |
| Amazon.com Inc | COM | 023135106 | 7,746,050 | 32,500 | SH | DFND | 2 | 32,500 | 0 | 0 | |
| Amylyx Pharmaceuticals Inc | COM | 03237H101 | 26,591,325 | 1,480,586 | SH | DFND | 2 | 1,480,586 | 0 | 0 | |
| Annexon Inc | COM | 03589W102 | 25,458,869 | 4,458,646 | SH | DFND | 2 | 4,458,646 | 0 | 0 | |
| Apple Inc | COM | 037833100 | 6,655,280 | 23,000 | SH | Call | DFND | 2 | 23,000 | 0 | 0 |
| Arcus Biosciences Inc | COM | 03969F109 | 20,823,507 | 675,430 | SH | DFND | 1 | 675,430 | 0 | 0 | |
| Arcus Biosciences Inc | COM | 03969F109 | 53,798,350 | 1,745,000 | SH | DFND | 2 | 1,745,000 | 0 | 0 | |
| Arrowhead Pharmaceuticals Inc | COM | 04280A100 | 139,828,449 | 1,715,476 | SH | DFND | 2 | 1,715,476 | 0 | 0 | |
| AT&T Inc | COM | 00206R102 | 517,500 | 25,000 | SH | DFND | 2 | 25,000 | 0 | 0 | |
| BeOne Medicines AG | SPONSORED ADS | 07725L102 | 132,511,050 | 465,000 | SH | DFND | 2 | 465,000 | 0 | 0 | |
| Bicara Therapeutics Inc | COM | 055477103 | 166,352,179 | 5,602,970 | SH | DFND | 2 | 5,602,970 | 0 | 0 | |
| Broadcom Inc | COM | 11135F101 | 9,443,750 | 25,000 | SH | DFND | 2 | 25,000 | 0 | 0 | |
| Capital One Finl Corp | COM | 14040H105 | 34,429,401 | 171,615 | SH | DFND | 1 | 171,615 | 0 | 0 | |
| Cellebrite DI Ltd | ORDINARY SHARES | M2197Q107 | 4,548,542 | 311,544 | SH | DFND | 2 | 311,544 | 0 | 0 | |
| Cogent Biosciences Inc | COM | 19240Q201 | 71,954,097 | 1,859,279 | SH | DFND | 2 | 1,859,279 | 0 | 0 | |
| Crinetics Pharmaceuticals Inc | COM | 22663K107 | 53,165,887 | 1,420,788 | SH | DFND | 2 | 1,420,788 | 0 | 0 | |
| CrowdStrike Holdings Inc | CL A | 22788C105 | 7,631,400 | 10,000 | SH | DFND | 2 | 10,000 | 0 | 0 | |
| Cullinan Therapeutics Inc | COM | 230031106 | 34,478,996 | 1,893,410 | SH | DFND | 2 | 1,893,410 | 0 | 0 | |
| Cytokinetics Inc | COM NEW | 23282W605 | 64,655,121 | 758,952 | SH | DFND | 2 | 758,952 | 0 | 0 | |
| CytomX Therapeutics Inc | COM | 23284F105 | 12,966,416 | 3,457,711 | SH | DFND | 2 | 3,457,711 | 0 | 0 | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 23,409,000 | 900,000 | SH | DFND | 2 | 900,000 | 0 | 0 | |
| Datadog Inc | CL A COM | 23804L103 | 10,414,400 | 40,000 | SH | DFND | 2 | 40,000 | 0 | 0 | |
| Dbv Technologies SA | SPONSORED ADS | 23306J309 | 30,460,737 | 1,857,362 | SH | DFND | 2 | 1,857,362 | 0 | 0 | |
| Definium Therapeutics Inc | COM SHS | 24477V105 | 66,772,951 | 1,419,493 | SH | DFND | 2 | 1,419,493 | 0 | 0 | |
| Denali Therapeutics Inc | COM | 24823R105 | 35,918,314 | 1,396,513 | SH | DFND | 2 | 1,396,513 | 0 | 0 | |
| Design Therapeutics Inc | COM | 25056L103 | 7,570,878 | 523,212 | SH | DFND | 2 | 523,212 | 0 | 0 | |
| Disc Medicine Inc | COM | 254604101 | 64,977,649 | 888,401 | SH | DFND | 2 | 888,401 | 0 | 0 | |
| Dynatrace, Inc | COM NEW | 268150109 | 6,806,050 | 155,000 | SH | DFND | 2 | 155,000 | 0 | 0 | |
| Dyne Therapeutics, Inc | COM | 26818M108 | 47,287,866 | 2,129,125 | SH | DFND | 2 | 2,129,125 | 0 | 0 | |
| Edgewise Therapeutics Inc | COM | 28036F105 | 129,391,476 | 3,184,629 | SH | DFND | 2 | 3,184,629 | 0 | 0 | |
| Eloxx Pharmaceuticals Inc | COM NEW | 29014R301 | 5,552,000 | 400,000 | SH | DFND | 2 | 400,000 | 0 | 0 | |
| enGene Therapeutics Inc | COM | 29286X101 | 10,824,025 | 6,256,662 | SH | DFND | 2 | 6,256,662 | 0 | 0 | |
| Enliven Therapeutics Inc | COM | 29337E102 | 90,051,358 | 1,774,411 | SH | DFND | 2 | 1,774,411 | 0 | 0 | |
| Entera Bio Ltd | SHS | M40527109 | 1,303,529 | 736,457 | SH | DFND | 2 | 736,457 | 0 | 0 | |
| Erasca Inc | COM | 29479A108 | 208,807,348 | 11,397,781 | SH | DFND | 2 | 11,397,781 | 0 | 0 | |
| Figma Inc | CLASS A COM STK | 316841105 | 904,500 | 50,000 | SH | DFND | 2 | 50,000 | 0 | 0 | |
| Foghorn Therapeutics Inc | COM | 344174107 | 3,517,114 | 720,720 | SH | DFND | 2 | 720,720 | 0 | 0 | |
| Fox Corp | CL A COM | 35137L105 | 521,600 | 10,000 | SH | DFND | 2 | 10,000 | 0 | 0 | |
| Generate Biomedicines Inc | COM SHS | 370920100 | 12,418,075 | 736,104 | SH | DFND | 2 | 736,104 | 0 | 0 | |
| GitLab Inc | CLASS A COM | 37637K108 | 3,816,250 | 125,000 | SH | DFND | 2 | 125,000 | 0 | 0 | |
| Gossamer Bio Inc | COM | 38341P102 | 857,396 | 5,208,968 | SH | DFND | 2 | 5,208,968 | 0 | 0 | |
| Hemab Therapeutics Holdings Inc | COM SHS | 423494103 | 76,649,413 | 2,086,834 | SH | DFND | 2 | 2,086,834 | 0 | 0 | |
| Inhibikase Therapeutics Inc | COM NEW | 45719W205 | 11,875,500 | 5,850,000 | SH | DFND | 2 | 5,850,000 | 0 | 0 | |
| Invivyd Inc | COM | 00534A102 | 4,362,000 | 5,000,000 | SH | DFND | 2 | 5,000,000 | 0 | 0 | |
| IONQ Inc | COM | 46222L108 | 9,054,200 | 170,000 | SH | DFND | 1 | 170,000 | 0 | 0 | |
| IREN Ltd | ORDINARY SHARES | Q4982L109 | 8,002,750 | 175,000 | SH | DFND | 2 | 175,000 | 0 | 0 | |
| Jfrog Ltd | ORD SHS | M6191J100 | 8,679,040 | 95,500 | SH | DFND | 2 | 95,500 | 0 | 0 | |
| Kailera Therapeutics Inc | COMMON STOCK | 482931102 | 48,780,721 | 2,214,286 | SH | DFND | 2 | 2,214,286 | 0 | 0 | |
| Kalaris Therapeutics Inc | COM | 482929106 | 1,773,698 | 435,798 | SH | DFND | 2 | 435,798 | 0 | 0 | |
| KE Holdings Inc | SPONSORED ADS | 482497104 | 1,453,000 | 100,000 | SH | DFND | 2 | 100,000 | 0 | 0 | |
| Korro Bio Inc | COM | 500946108 | 4,582,923 | 347,718 | SH | DFND | 2 | 347,718 | 0 | 0 | |
| Kymera Therapeutics Inc | COM | 501575104 | 336,651,626 | 2,935,830 | SH | DFND | 2 | 2,935,830 | 0 | 0 | |
| Lexicon Pharmaceuticals Inc | COM NEW | 528872302 | 106,328,443 | 44,303,518 | SH | DFND | 2 | 44,303,518 | 0 | 0 | |
| Lumentum Holdings Inc | COM | 55024U109 | 905,253 | 1,055 | SH | DFND | 2 | 1,055 | 0 | 0 | |
| MapLight Therapeutics Inc | COM | 56565P103 | 16,128,000 | 450,000 | SH | DFND | 2 | 450,000 | 0 | 0 | |
| Medline Inc | COM CL A | 58507V107 | 986,000 | 25,000 | SH | DFND | 2 | 25,000 | 0 | 0 | |
| Microsoft Corp | COM | 594918104 | 13,988,250 | 37,500 | SH | DFND | 2 | 37,500 | 0 | 0 | |
| Microsoft Corp | COM | 594918104 | 8,952,480 | 24,000 | SH | Call | DFND | 2 | 24,000 | 0 | 0 |
| monday.com Ltd | SHS | M7S64H106 | 3,076,575 | 42,500 | SH | DFND | 2 | 42,500 | 0 | 0 | |
| Monopar Therapeutics Inc | COM NEW | 61023L207 | 25,010,226 | 270,118 | SH | DFND | 2 | 270,118 | 0 | 0 | |
| Nebius Group NV | SHS CLASS A | N97284108 | 14,360,840 | 52,000 | SH | DFND | 2 | 52,000 | 0 | 0 | |
| Netflix Inc | COM | 64110L106 | 1,784,925 | 25,000 | SH | DFND | 2 | 25,000 | 0 | 0 | |
| Neumora Therapeutics Inc | COM | 640979100 | 14,446,297 | 8,497,822 | SH | DFND | 2 | 8,497,822 | 0 | 0 | |
| NovaBridge Biosciences | SPONSORED ADS | 44975P103 | 3,909,241 | 2,004,739 | SH | DFND | 2 | 2,004,739 | 0 | 0 | |
| Nu Holdings Ltd. | ORD SHS CL A | G6683N103 | 334,000 | 25,000 | SH | DFND | 2 | 25,000 | 0 | 0 | |
| NVIDIA Corp | COM | 67066G104 | 19,008,550 | 95,000 | SH | DFND | 2 | 95,000 | 0 | 0 | |
| Oculis Holding AG | ORDINARY SHARES | H5870P102 | 8,668,750 | 625,000 | SH | DFND | 2 | 625,000 | 0 | 0 | |
| Odyssey Therapeutics Inc | COMMON STOCK | 67613T104 | 3,742,000 | 200,000 | SH | DFND | 2 | 200,000 | 0 | 0 | |
| Olema Pharmaceuticals Inc | COM | 68062P106 | 60,760,432 | 4,856,949 | SH | DFND | 2 | 4,856,949 | 0 | 0 | |
| Oric Pharmaceuticals Inc | COM | 68622P109 | 10,912,037 | 1,007,575 | SH | DFND | 1 | 1,007,575 | 0 | 0 | |
| Oric Pharmaceuticals Inc | COM | 68622P109 | 21,558,382 | 1,990,617 | SH | DFND | 2 | 1,990,617 | 0 | 0 | |
| Oruka Therapeutics Inc | COM | 687604108 | 23,792,500 | 250,000 | SH | DFND | 2 | 250,000 | 0 | 0 | |
| Ouster Inc | COM NEW | 68989M202 | 4,220,100 | 67,500 | SH | DFND | 2 | 67,500 | 0 | 0 | |
| Palisade Bio Inc | COM | 696389402 | 4,180,000 | 2,000,000 | SH | DFND | 2 | 2,000,000 | 0 | 0 | |
| Palvella Therapeutics Inc | COM | 697947109 | 39,348,858 | 257,485 | SH | DFND | 2 | 257,485 | 0 | 0 | |
| Parabilis Medicines Inc | COM | 698955101 | 81,898,129 | 2,992,259 | SH | DFND | 2 | 2,992,259 | 0 | 0 | |
| PDD Holdings Inc | SPONSORED ADS | 722304102 | 7,246,600 | 95,000 | SH | DFND | 2 | 95,000 | 0 | 0 | |
| Quantinuum Inc | CL A COM | 74768A104 | 1,634,800 | 20,000 | SH | DFND | 2 | 20,000 | 0 | 0 | |
| Rani Therapeutics Holdings Inc | COM CL A | 753018100 | 1,520,800 | 2,000,000 | SH | DFND | 2 | 2,000,000 | 0 | 0 | |
| Rapport Therapeutics Inc | COM | 75383L102 | 26,730,013 | 641,469 | SH | DFND | 2 | 641,469 | 0 | 0 | |
| Relay Therapeutics Inc | COM | 75943R102 | 68,291,500 | 3,650,000 | SH | DFND | 2 | 3,650,000 | 0 | 0 | |
| Remitly Global Inc | COM | 75960P104 | 34,584,703 | 1,543,271 | SH | DFND | 1 | 1,543,271 | 0 | 0 | |
| Revolution Medicines Inc | COM | 76155X100 | 168,552,000 | 900,000 | SH | DFND | 2 | 900,000 | 0 | 0 | |
| Rezolute Inc | COM NEW | 76200L309 | 17,307,092 | 3,328,287 | SH | DFND | 2 | 3,328,287 | 0 | 0 | |
| Rhythm Pharmaceuticals Inc | COM | 76243J105 | 126,160,613 | 1,136,275 | SH | DFND | 2 | 1,136,275 | 0 | 0 | |
| Satellos Bioscience Inc | COM | 80401L803 | 6,935,875 | 892,074 | SH | DFND | 2 | 892,074 | 0 | 0 | |
| Scholar Rock Holding Corp | COM | 80706P103 | 526,625,715 | 9,575,013 | SH | DFND | 2 | 9,575,013 | 0 | 0 | |
| Seaport Therapeutics Inc | COMMON STOCK | 81221K108 | 23,790,264 | 1,095,316 | SH | DFND | 2 | 1,095,316 | 0 | 0 | |
| Seer Inc | COM CL A | 81578P106 | 4,081,397 | 2,458,673 | SH | DFND | 2 | 2,458,673 | 0 | 0 | |
| Septerna Inc | COM | 81734D104 | 63,631,000 | 1,900,000 | SH | DFND | 2 | 1,900,000 | 0 | 0 | |
| ServiceNow Inc | COM | 81762P102 | 9,928,000 | 100,000 | SH | DFND | 2 | 100,000 | 0 | 0 | |
| Silence Therapeutics PLC | ADS | 82686Q101 | 36,359,589 | 3,311,438 | SH | DFND | 2 | 3,311,438 | 0 | 0 | |
| Sionna Therapeutics Inc | COM | 829401108 | 26,856,555 | 610,515 | SH | DFND | 2 | 610,515 | 0 | 0 | |
| Solid Biosciences Inc | COM NEW | 83422E204 | 76,827,146 | 7,690,405 | SH | DFND | 2 | 7,690,405 | 0 | 0 | |
| Spyre Therapeutics Inc | COM NEW | 00773J202 | 85,992,130 | 968,598 | SH | DFND | 2 | 968,598 | 0 | 0 | |
| Stoke Therapeutics Inc | COM | 86150R107 | 65,287,754 | 1,995,347 | SH | DFND | 2 | 1,995,347 | 0 | 0 | |
| Structure Therapeutics Inc | SPONSORED ADS | 86366E106 | 46,852,139 | 872,967 | SH | DFND | 2 | 872,967 | 0 | 0 | |
| Taboola.com Ltd | ORD SHS | M8744T106 | 42,117,050 | 8,423,410 | SH | DFND | 1 | 8,423,410 | 0 | 0 | |
| Taiwan Semiconductor Manufacturing Co Ltd | SPONSORED ADS | 874039100 | 21,347,379 | 44,700 | SH | DFND | 2 | 44,700 | 0 | 0 | |
| Tango Therapeutics Inc | COM | 87583X109 | 193,166,919 | 6,179,364 | SH | DFND | 2 | 6,179,364 | 0 | 0 | |
| Taysha Gene Therapies Inc | COM SHS | 877619106 | 67,055,203 | 9,846,579 | SH | DFND | 2 | 9,846,579 | 0 | 0 | |
| Tenax Therapeutics Inc | COM NEW | 88032L605 | 6,214,902 | 427,141 | SH | DFND | 2 | 427,141 | 0 | 0 | |
| Tesla Inc | COM | 88160R101 | 1,472,100 | 3,500 | SH | DFND | 2 | 3,500 | 0 | 0 | |
| Trevi Therapeutics Inc | COM | 89532M101 | 33,325,070 | 1,786,867 | SH | DFND | 2 | 1,786,867 | 0 | 0 | |
| Tyra Biosciences Inc | COM | 90240B106 | 23,156,500 | 725,000 | SH | DFND | 2 | 725,000 | 0 | 0 | |
| Veradermics Inc | COMMON STOCK | 922967104 | 203,511,680 | 1,655,374 | SH | DFND | 2 | 1,655,374 | 0 | 0 | |
| vTv Therapeutics Inc | CL A NEW | 918385204 | 6,136,950 | 163,000 | SH | DFND | 2 | 163,000 | 0 | 0 | |
| Whitehawk Therapeutics Inc | COM | 00032Q104 | 10,703,927 | 2,337,102 | SH | DFND | 2 | 2,337,102 | 0 | 0 | |
| Workiva Inc | COM CL A | 98139A105 | 2,182,950 | 45,000 | SH | DFND | 2 | 45,000 | 0 | 0 | |
| Xenon Pharmaceuticals Inc | COM | 98420N105 | 79,588,523 | 1,318,564 | SH | DFND | 2 | 1,318,564 | 0 | 0 | |
| Zoetis Inc | CL A | 98978V103 | 2,515,100 | 35,000 | SH | DFND | 2 | 35,000 | 0 | 0 | |
| Zura Bio Ltd | CLASS A ORD SHS | G9TY5A101 | 22,035,709 | 3,734,866 | SH | DFND | 2 | 3,734,866 | 0 | 0 | |